Morphine in the treatment of pain in patients with the advanced cancer.  <br>Do we know it well? How to use it safely?

Aleksandra Kotlińska-Lemieszek; Ewa Bączyk; Aleksandra Ciałkowska-Rysz; Jacek Łuczak

eISSN: 2081-2833
ISSN: 2081-0016

Medycyna Paliatywna/Palliative Medicine

Current issue Archive Manuscripts accepted About the journal Editorial board Abstracting and indexing Subscription Contact Instructions for authors Publication charge Ethical standards and procedures

Editorial System

Submit your Manuscript

2/2010
vol. 2

Send email

Copy url:

abstract:

Review paper

Morphine in the treatment of pain in patients with the advanced cancer.
Do we know it well? How to use it safely?

Aleksandra Kotlińska-Lemieszek

,

Ewa Bączyk

,

Aleksandra Ciałkowska-Rysz

,

Jacek Łuczak

Medycyna Paliatywna 2010; 2: 67–80

Online publish date: 2010/07/05

View full text Get citation

The characteristics of oral and parenteral morphine with the focus on pharmacokinetic parameters essential for clinical practice, adverse effects and interactions, was presented in the paper. Updated recommendations concerning morphine based on over 20 years of experience with World Health Organization principles of cancer pain management, including elderly and the patients with liver and renal insufficiency, were described.

keywords:

Morphine in the treatment of pain in patients with the advanced cancer. Do we know it well? How to use it safely?

Aleksandra Kotlińska-Lemieszek , Ewa Bączyk , Aleksandra Ciałkowska-Rysz , Jacek Łuczak

morphine, cancer pain, recommendations, opioid rotation, combined opioid therapy

Morphine in the treatment of pain in patients with the advanced cancer.
Do we know it well? How to use it safely?

Aleksandra Kotlińska-Lemieszek

,

Ewa Bączyk

,

Aleksandra Ciałkowska-Rysz

,

Jacek Łuczak